0001209191-22-003268.txt : 20220114 0001209191-22-003268.hdr.sgml : 20220114 20220114090121 ACCESSION NUMBER: 0001209191-22-003268 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220113 FILED AS OF DATE: 20220114 DATE AS OF CHANGE: 20220114 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Piekos Brian CENTRAL INDEX KEY: 0001815308 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39438 FILM NUMBER: 22530534 MAIL ADDRESS: STREET 1: C/O AMAG PHARMACEUTICALS, INC. STREET 2: 1100 WINTER STREET CITY: WALTHAM STATE: MA ZIP: 02451 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Gemini Therapeutics, Inc. /DE CENTRAL INDEX KEY: 0001816736 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 851613057 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 300 ONE KENDALL SQUARE, 3RD FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: (617) 401-4400 MAIL ADDRESS: STREET 1: 300 ONE KENDALL SQUARE, 3RD FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02139 FORMER COMPANY: FORMER CONFORMED NAME: FS Development Corp. DATE OF NAME CHANGE: 20200702 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-01-13 0 0001816736 Gemini Therapeutics, Inc. /DE GMTX 0001815308 Piekos Brian C/O GEMINI THERAPEUTICS, INC. NOT APPLICABLE DE 0 1 0 0 CFO Restricted Stock Units 2022-01-13 4 A 0 280876 0.00 A Common Stock 280876 280876 D Each restricted stock unit represents the right to receive one share of Gemini Therapeutics, Inc. common stock. These Restricted Stock Units shall vest on the one (1)-year anniversary of the date of grant. /s/ Brian Piekos 2022-01-14